Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Hepatol. Sep 27, 2013; 5(9): 505-512
Published online Sep 27, 2013. doi: 10.4254/wjh.v5.i9.505
Table 1 Body mass index -z score, fat fraction, liver echogenicity, liver biochemical parameters and lipid profile of the studied population at baseline and at the end of intervention, values are mean (SD)+ and median or number of observation (%)
VariableBaseline (n = 46)End of intervention (n = 46)1P value
BMI Z score2.3 (0.4); 2.11.90 (0.6); 1.9< 0.001
Fat fraction (%)7.8 (13.3)0.01 (8.3)< 0.001
FF ≥ 5%21 (45.7)5 (10.9)< 0.001
FF ≥ 9%16 (34.8)4 (8.7)< 0.001
Liver echogenicity (%)
025 (54.3)36 (78.3)< 0.0001
114 (30.4)9 (19.6)
26 (13.0)1 (2.2)
31 (2.2)0 (0.0)
ALT (UI/L)34.8 (12.0); 29.023.8 (8.70); 22.50< 0.001
AST (UI/L)30.7 (10.1); 29.025.9 (7.50); 26.00< 0.001
γGT (UI/L)15.7 (5.2); 15.013.1 (3.80); 12.00< 0.001
Total cholesterol (mmol/L)4.39 (0.70); 4.484.30 (0.76); 4.230.211
HDL cholesterol (mmol/L)1.22 (0.24); 1.231.21 (0.22); 1.240.916
LDL cholesterol (mmol/L)2.64 (0.59); 2.602.60 (0.67); 2.560.306
Triglycerides (mmol/L)1.31 (0.62); 1.200.99 (0.46); 0.94< 0.001
Apo A1 (g/L)1.24 (0.21); 1.211.28 (0.21); 1.260.122
Apo B (g/L)0.73 (0.17); 0.700.66 (0.15); 0.670.022